Lack of Nephrotoxicity with the Administration of Amphotericin B in a Lipid Emulsion

Abstract

Get full access to this article

View all access options for this article.

References

Chavanet

Garry

Charlier

Caillot

Kisterman

D'Athis

. Trial of glucose versus fat emulsion in preparation of amphotericin B for use in HIV infected patients with candidiasis. BMJ 1992; 305: 921–5.

Caillot

Chavanet

Casasnovas

Solary

Zanetta

Buisson

. Clinical evaluation of a new lipid-based delivery system for intravenous administration of amphotericin B. Eur J Clin Microbiol Infect Dis 1992; 11: 722–5.

Moreau

Milpied

Fayette

Ramée

Harousseau

. Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with Intralipid compared with conventional amphotericin B in neutropenic patients. J Antimicrob Chemother 1992; 30: 535–41.

Caillot

Casasnovas

Solary

Chavanet

Bonnotte

Reny

. Efficacy and tolerance of an amphotericin B lipid (Intralipid) emulsion in the treatment of candidemia in neutropenic patients. J Antimicrob Chemother 1993; 31: 161–9.